Home/NOVITÀ/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesTIF News (IT)NOVITÀ TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Meno di un minuto 211020_ TIF Announcement_COVID-19 Vaccine Boosters TagCOVID-19 Pandemic Vulnerable COVID-19 Vaccines AtRisk Thalassaemia Haemoglobin Disorders Vaccinations COVID-19 TIF News #news Sickle cell Healthcare Professionals Patients Meno di un minuto Facebook Twitter LinkedIn Condividi via mail Stampa
